|
1
|
Olah KS, Gee H, Blunt S, Dunn JA, Kelly K
and Chan KK: Retrospective analysis of 318 cases of uterine
sarcoma. Eur J Cancer. 27:1095–1099. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harlow BL, Weiss NS and Lofton S: The
epidemiology of sarcomas of the uterus. J Natl Cancer Inst.
76:399–402. 1986.PubMed/NCBI
|
|
3
|
Evans HL: Endometrial stromal sarcoma and
poorly differentiated endometrial sarcoma. Cancer. 50:2170–2182.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Amant F, Vergote I and Moerman P: The
classification of a uterine sarcoma as ‘high-grade endometrial
stromal sarcoma’ should be abandoned. Gynecol Oncol. 95:412–413.
(author reply 413). 2004.PubMed/NCBI
|
|
5
|
Reich O and Regauer S: Survey of adjuvant
hormone therapy in patients after endometrial stromal sarcoma. Eur
J Gynaecol Oncol. 27:150–152. 2006.PubMed/NCBI
|
|
6
|
Pink D, Lindner T, Mrozek A, Kretzschmar
A, Thuss-Patience PC, Dörken B and Reichardt P: Harm or benefit of
hormonal treatment in metastatic low-grade endometrial stromal
sarcoma: Single center experience with 10 cases and review of the
literature. Gynecol Oncol. 101:464–469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ashraf-Ganjoei T, Behtash N, Shariat M and
Mosavi A: Low grade endometrial stromal sarcoma of uterine corpus,
a clinico-pathological and survey study in 14 cases. World J Surg
Oncol. 4:502006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amant F, Moerman P, Cadron I, Neven P,
Berteloot P and Vergote I: The diagnostic problem of endometrial
stromal sarcoma: Report on six cases. Gynecol Oncol. 90:37–43.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reich O and Regauer S: Hormonal therapy of
endometrial stromal sarcoma. Curr Opin Oncol. 19:347–352. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. European
Organization for Research and Treatment of Cancer, National Cancer
Institute of the United States, National Cancer Institute of
Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maluf FC, Sabbatini P, Schwartz L, Xia J
and Aghajanian C: Endometrial stromal sarcoma: Objective response
to letrozole. Gynecol Oncol. 82:384–388. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spano JP, Soria JC, Kambouchner M,
Piperno-Neuman S, Morin F, Morere JF, Martin A and Breau JL:
Long-term survival of patients given hormonal therapy for
metastatic endometrial stromal sarcoma. Med Oncol. 20:87–93. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leunen M, Breugelmans M, De Sutter P,
Bourgain C and Amy JJ: Low-grade endometrial stromal sarcoma
treated with the aromatase inhibitor letrozole. Gynecol Oncol.
95:769–771. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leiser AL, Hamid AM and Blanchard R:
Recurrence of prolactin-producing endometrial stromal sarcoma with
sex-cord stromal component treated with progestin and aromatase
inhibitor. Gynecol Oncol. 94:567–571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brechot JM, Kamboucher M, Brauner M,
Destable M, Duperron F and Morère JF: Pulmonary metastases from
endometrial stromal sarcoma may benefit from hormone therapy. Rev
Mal Respir. 24:69–72. 2007.(In French). PubMed/NCBI
|
|
16
|
Landréat V, Paillocher N, Catala L,
Foucher F, Descamps P and Levêque J: Low-grade endometrial stromal
sarcoma of the uterus: Review of 10 cases. Anticancer Res.
28:2869–2874. 2008.PubMed/NCBI
|
|
17
|
Krauss K, Bachmann C, Hartmann JT,
Siegmann K, Sotlar K, Wallwiener D and Huober J: Management of late
recurrence of a low-grade endometrial stromal sarcoma (LGESS):
Treatment with letrozole. Anticancer Res. 27:3477–3480.
2007.PubMed/NCBI
|
|
18
|
Alkasi O, Meinhold-Heerlein I, Zaki R,
Fasching P, Maass N, Jonat W and Beckmann MW: Long-term
disease-free survival after hormonal therapy of a patient with
recurrent low grade endometrial stromal sarcoma: A case report.
Arch Gynecol Obstet. 279:57–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tzakas E, Liu S, Todd RW and Redman CW:
Hormonal therapy with letrozole prior to surgical management of
recurrent metastatic low-grade endometrial stromal sarcoma (LGESS).
J Obstet Gynaecol. 29:778–779. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dahhan T, Fons G, Buist MR, Ten Kate FJ
and van der Velden J: The efficacy of hormonal treatment for
residual or recurrent low-grade endometrial stromal sarcoma. A
retrospective study. Eur J Obstet Gynecol Reprod Biol. 144:80–84.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ioffe YJ, Li AJ, Walsh CS, Karlan BY,
Leuchter R, Forscher C and Cass I: Hormone receptor expression in
uterine sarcomas: Prognostic and therapeutic roles. Gynecol Oncol.
115:466–471. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sylvestre VT and Dunton CJ: Treatment of
recurrent endometrial stromal sarcoma with letrozole: A case report
and literature review. Horm Cancer. 1:112–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shoji K, Oda K, Nakagawa S, Kawana K,
Yasugi T, Ikeda Y, Takazawa Y, Kozuma S and Taketani Y: Aromatase
inhibitor anastrozole as a second-line hormonal treatment to a
recurrent low-grade endometrial stromal sarcoma: A case report. Med
Oncol. 28:771–774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Altman AD, Nelson GS, Chu P, Nation J and
Ghatage P: Uterine sarcoma and aromatase inhibitors: Tom baker
cancer centre experience and review of the literature. Int J
Gynecol Cancer. 22:1006–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Balleine RL, Earls PJ, Webster LR, Mote
PA, de Fazio A, Harnett PR and Clarke CL: Expression of
progesterone receptor A and B isoforms in low-grade endometrial
stromal sarcoma. Int J Gynecol Pathol. 23:138–144. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chu MC, Mor G, Lim C, Zheng W, Parkash V
and Schwartz PE: Low-grade endometrial stromal sarcoma: Hormonal
aspects. Gynecol Oncol. 90:170–176. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reich O, Regauer S, Urdl W, Lahousen M and
Winter R: Expression of oestrogen and progesterone receptors in
low-grade endometrial stromal sarcomas. Br J Cancer. 82:1030–1034.
2000.PubMed/NCBI
|
